Items Tagged ‘#preemptive pharmacogenomics’
December 31, 2018
The growing role of genetic nurses: educating, empowering patients
By Sharon Rosen 
As genetic sequencing has become faster and cheaper, more people are considering predictive genetic testing to identify their future risk for disease, with the goal of taking charge of their health. Yet many face the challenge of understanding which genetic testing option would fit their health goals. While genetic counselors have traditionally helped patients through […]
Tags: #Corinne Berg, #genetic counselor shortage, #genetic nurses, #Genetics education, #hereditary diseases, #hereditary heart disease, #predictive genomics, #preemptive pharmacogenomics, #Therese Hughes, DNA Testing, Genetic Counselors, genomics
July 3, 2017
Trying to quit smoking? Genetics may help find the right plan for success
By Sharon Rosen
After trying different methods, why do many people have difficulty quitting smoking? That’s a question Rachel Tyndale, Ph.D., is asking as part of her research into smoking cessation therapy. As senior scientist and head of the Pharmacogenetics Lab in the Campbell Family Mental Health Research Institute at University of Toronto, Dr. Tyndale is using molecular […]
Tags: #CIMCon17, #DNA analysis, #Dr. J. Steven Leeder, #Dr. Rachel Tyndale, #drug-gene reactions, #Individualizing Medicine 2017, #preemptive pharmacogenomics, #smoking cessation, center for individualized medicine, DNA Sequencing, Dr. Eric Matey, Dr. Liewei Wang
October 18, 2016
Embrace Pharmacogenomics in Your Practice
By Sharon Rosen
Article by Rachel Guibert, Public Affairs Currently, a population with a given disease generally receives the same therapy for all patients. Pharmacogenomics will change this ‘one-size-fits-all’ approach to drug treatments. Konstantinos Lazaridis, M.D., Eric Matey, Pharm.D., R.Ph., and Jeffrey Bishop, Pharm.D., M.S., B.C.P.P., are expecting a future practice reality in which clinicians will have every […]
Tags: #Dr. Jeffrey Bishop, #drug-gene reactions, #preemptive pharmacogenomics, center for individualized medicine, Dr. Eric Matey, Dr. Konstantinos Lazaridis, mayo clinic, PGx, pharmacogenomics